|
AnteparDrug - Antepar The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Piperazine Citrate
Strength -
EQ 500MG BASE
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
009102
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Antepar
Multifuge Eq 500mg Base/5ml Syrup; Oral
Piperazine Citrate Eq 500mg Base/5ml Syrup; Oral Piperazine Citrate Eq 500mg Base/5ml Syrup; Oral Piperazine Citrate Eq 500mg Base/5ml Syrup; Oral Vermidol Eq 500mg Base/5ml Syrup; Oral Antepar Eq 500mg Base Tablet; Oral Zosyn In Plastic Container Eq 4gm Base/100ml;eq 500mg Base/100ml Injectable; Injection Zosyn In Plastic Container Eq 60mg Base/ml;eq 7.5mg Base/ml Injectable; Injection Antepar Eq 500mg Base/5ml Syrup; Oral Bryrel Eq 500mg Base/5ml Syrup; Oral NewDrugInformation |